It was the third trigger of the recession indicator in less than two weeks.Bondsread more
U.S. manufacturer growth slowed to the lowest in almost 10 years in August, the latest sign that the trade war may be exacerbating the economic slowdown.Marketsread more
"My sense was we've added accommodation, and it wasn't required in my view," George tells CNBC's Steve Liesman.Investingread more
Stocks fell as fears of an economic recession built up ahead of a key speech from Federal Reserve Chairman Jerome Powell.US Marketsread more
Apple plans to unveil three new iPhones in September, including two new "Pro" models and a successor to the iPhone XR, Bloomberg reported Thursday.Technologyread more
Former Prudent Bear Fund manager David Tice is urging investors to brace for a massive downturn.Trading Nationread more
Corporate profits posted modest growth in the second quarter as companies brace for slowing global growth.Retailread more
A Volkswagen spokesperson called the report that CEO Herbert Diess is interested in buying a stake in Tesla "completely unfounded."Technologyread more
A ruling against J&J could mean more big payouts in similar cases across the country.Health and Scienceread more
(Adds details on the deal)
May 2 (Reuters) - 3M Co said on Thursday it would buy privately held medical device maker Acelity Inc in a deal valued at $6.7 billion, including debt, as the U.S. industrial conglomerate looks to expand its business in medical dressings and related products.
Acelity, under its KCI brand, makes advanced wound dressings and specialized systems that seal off wounds that continue to leak blood after surturing. It had revenue of $1.5 billion in 2018.
3M said Acelity will become part of its medical solutions business that makes medical tapes, sterilization products and acute wound care dressings products.
3M is buying the company and some of its units from a consortium of funds advised by Apax Partners, affiliates of Canada Pension Plan Investment Board and the Public Sector Pension Investment Board.
The deal is expected to close in the second half of 2019.
3M also said it now expects full-year 2019 share repurchases to be in the range of $1.0 billion to $1.5 billion, compared with a prior range of $2.0 billion to $4.0 billion. (Reporting by Ankit Ajmera in Bengaluru; Editing by Arun Koyyur)